Portugal launches COPD detection programme
This article was originally published in Clinica
Portugal has begun to roll out a national chronic obstructive pulmonary disorder (COPD) early detection programme. The initiative features the provision of spirometry and other diagnostic equipment in mobile units that are designed to complement local primary care provision. The aim of the programme is to improve early detection rates and improve care outcomes; until now, COPD diagnosis has only been offered through hospital referral. The condition affects more than 5% of the Portuguese population, according to the health ministry. The programme was launched in Portugal's northern region; it is scheduled to be extended across the Lisbon North area by the end of this month.
You may also be interested in...
Having had a very fruitful year in terms of regulatory approvals, the Swiss major will reveal how successful its new products have been commercially. Of particular interest will be the performance of eye drug Beovu as it takes on Bayer's rival Eylea.
Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine, And Zimmer Biomet Fills Communications Spot
Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.